George Clinical adds Philippines office to APAC lineup

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Derek Brumby)
(Image: Getty/Derek Brumby)

Related tags: George Clinical, Philippines, Asia pacific, Clinical trials, Clinical research

Headquartered in the Asia-Pacific, George Clinical deepens its footprint in the region with a new office in Manila, Philippines.

In an aim to collaborate, the global clinical research organization (CRO) opened another office in the Asia-Pacific (APAC). With its base in Australia, George Clinical has facilities in China, India, Hong Kong, South Korea, Taiwain, Malaysia, the UK, and the US. However, it provides services outside of those countries and has previously provided services directly to the Philippines.  

George Clinical opened this office in an aim to formalize the company’s collaborations within the area. According to the CRO, the Philippines was chosen strategically as it is not only a strong part of the region’s clinical trial landscape, but it has a large population of treatment naïve patients.

Additionally, it will enable the company to increase its investigational networks that may enhance study quality, performance, and efficiency.

The company explained in a statement that the Philippines has a strong track record in its conduct during trials for infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials, which corresponds with the studies George Clinical intends to focus on in the country.  

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars